We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Arena’s Lorcaserin Doesn’t Meet FDA’s Bar for Weight-Loss Drugs
Arena’s Lorcaserin Doesn’t Meet FDA’s Bar for Weight-Loss Drugs
October 27, 2010
Sponsors developing prescription weight-loss drugs have a high hurdle to gain agency approval if the FDA’s action letter to Arena Pharmaceuticals regarding lorcaserin is any indication.